129 related articles for article (PubMed ID: 2567549)
1. Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia.
Kitagawa M; Kamiyama R; Takemura T; Kasuga T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(1):47-53. PubMed ID: 2567549
[TBL] [Abstract][Full Text] [Related]
2. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
[TBL] [Abstract][Full Text] [Related]
3. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia.
Kitagawa M; Kamiyama R; Kasuga T
Hum Pathol; 1993 Apr; 24(4):359-63. PubMed ID: 8098317
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
5. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M
Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814
[TBL] [Abstract][Full Text] [Related]
6. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
7. [Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies].
Navone R; Ranco V; Pich A
Pathologica; 1991; 83(1083):55-63. PubMed ID: 1866200
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes: evolution of overt leukaemia by one or several steps of transformation.
Dörmer P; Hershko C; Voss R; Wilmanns W
Br J Haematol; 1987 Oct; 67(2):141-6. PubMed ID: 3676102
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
10. Hypoplastic myelodysplastic syndrome.
Nand S; Godwin JE
Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
[TBL] [Abstract][Full Text] [Related]
11. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.
Saad ST; Vassallo J; Arruda VA; Lorand-Metze I
Pathologica; 1994 Feb; 86(1):47-51. PubMed ID: 8072801
[TBL] [Abstract][Full Text] [Related]
12. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
13. Hypocellular myelodysplastic syndromes: clinical and biological significance.
Marisavljevic D; Cemerikic V; Rolovic Z; Boskovic D; Colovic M
Med Oncol; 2005; 22(2):169-75. PubMed ID: 15965280
[TBL] [Abstract][Full Text] [Related]
14. Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Schemenau J; Baldus S; Anlauf M; Reinecke P; Braunstein S; Blum S; Nachtkamp K; Neukirchen J; Strup C; Aul C; Haas R; Gattermann N; Germing U
Eur J Haematol; 2015 Sep; 95(3):181-9. PubMed ID: 25600827
[TBL] [Abstract][Full Text] [Related]
15. [Pathohistological characteristics of myelodysplastic syndromes: diagnostic and prognostic significance].
Marisavljević D; Cemerikić V; Rolović Z; Bosković D; Colović M
Srp Arh Celok Lek; 2005; 133(3-4):162-9. PubMed ID: 16206706
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
[TBL] [Abstract][Full Text] [Related]
17. High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes.
Mittelman M; Karcher DS; Kammerman LA; Lessin LS
Am J Hematol; 1993 Jul; 43(3):165-71. PubMed ID: 8352230
[TBL] [Abstract][Full Text] [Related]
18. Hypocellular myelodysplastic syndromes (MDS): new proposals.
Tuzuner N; Cox C; Rowe JM; Watrous D; Bennett JM
Br J Haematol; 1995 Nov; 91(3):612-7. PubMed ID: 8555063
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
20. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
Kikuchi M; Ohshima K; Kobari S
Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]